Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Other Non Operating Income (2023 - 2025)

CG Oncology (CGON) has disclosed Other Non Operating Income for 3 consecutive years, with -$53000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non Operating Income fell 983.33% year-over-year to -$53000.0, compared with a TTM value of -$152000.0 through Dec 2025, down 5166.67%, and an annual FY2025 reading of -$152000.0, down 5166.67% over the prior year.
  • Other Non Operating Income was -$53000.0 for Q4 2025 at CG Oncology, up from -$100000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $8000.0 in Q1 2023 and bottomed at -$100000.0 in Q3 2025.
  • Average Other Non Operating Income over 3 years is -$17583.3, with a median of -$4000.0 recorded in 2023.
  • The sharpest move saw Other Non Operating Income surged 250.0% in 2024, then tumbled 4900.0% in 2025.
  • Year by year, Other Non Operating Income stood at -$4000.0 in 2023, then soared by 250.0% to $6000.0 in 2024, then tumbled by 983.33% to -$53000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for CGON at -$53000.0 in Q4 2025, -$100000.0 in Q3 2025, and -$4000.0 in Q2 2025.